Other pharmaceutical companies are also entering the race to develop oral GLP-1 treatments. Eli Lilly is testing an experimental drug called orforglipron which targets the same pathway as semaglutide.

Each of these ingredients has been studied for its potential to influence GLP-1 pathways or mimic some of the effects of GLP-1. Let’s take a closer look at each of these ingredients and the scientific ...

The medtech industry hopes to capitalise on increased awareness about the obesity space to promote multidisciplinary ...

Discover what the supplement Lemme GLP-1 Daily does and whether its ingredients are really effective for weight and blood ...

Representational Photo The exploration of novel peptides for their potential impact on metabolic pathways has been a ...

This year's recipients have been recognised for their work on the HIV epidemic, GLP-1-based drugs, and how DNA can stimulate ...

Six individuals have received this year's Lasker Awards in the areas of basic research, clinical research, and public service ...

Semaglutide injections effectively support weight loss by regulating appetite and glucose levels, offering benefits for ...

Half a century of advancements in biomedical science paved the way for today's powerful weight-loss drugs like Ozempic -- so ...

Three doctors have expressed concerns to Newsweek about weight loss drugs for children, with research suggesting an initial reluctance to prescribe them.

Kourtney, the one who married Travis Barker and sees herself as ‘not like the other Kardashians,’ has a supplements line ...

Half a century of advancements in biomedical science paved the way for today's powerful weight-loss drugs like Ozempic—so ...